Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Investors increased their allocations to pharmaceuticals (NYSEARCA:PJP), (NYSEARCA:XPH), (PPH), banks (KRE) and industrials ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

With the respiratory illness season starting up in earnest, Vicks has reclaimed the top Rx and over-the-counter (OTC) pharma ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...

Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic, has asked the US authorities to ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...

BEIJING -- China has highlighted its commitment to encouraging the long-term operation and development of foreign-funded ...